XML 24 R6.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Common Stock
Series B Cumulative Redeemable Preferred Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Compreh-ensive Income (Loss)
Non- controlling Interests — Common units in the Operating Partnership
Non-controlling Interest — Members in Consolidated Entities
Beginning balance (in shares) at Dec. 31, 2013   57,230,199            
Beginning balance at Dec. 31, 2013 $ 1,102,866 $ 572 $ 145,000 $ 903,984 $ (45,113) $ (997) $ 53,737 $ 45,683
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Distributions (2,842)             (2,842)
Proceeds from sale of common stock, net of underwriters' discount (in shares)   9,563,500            
Proceeds from sale of common stock, net of underwriters’ discount and transaction costs 195,869 $ 96   195,773        
Issuance of unrestricted stock (in shares)   6,922            
Issuance of unrestricted stock 0 $ 0   0        
Shares withheld to satisfy minimum tax withholding (in shares)   (2,805)            
Shares withheld to satisfy tax withholding (3,129) $ 0   (3,129)        
Declared dividend (47,110)   (12,144) (33,774)     (1,192)  
Amortization of stock-based compensation 7,979     7,979        
Net income 22,881   12,144   10,229   359 149
Change in fair value of derivatives (1,499)         (1,446) (53)  
Change in fair value of derivatives (1,499)              
Ending balance (in shares) at Dec. 31, 2014   66,797,816            
Ending balance at Dec. 31, 2014 1,275,015 $ 668 145,000 1,070,833 (34,884) (2,443) 52,851 42,990
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Contributions 217,795             217,795
Distributions (2,013)             (2,013)
Proceeds from sale of common stock, net of underwriters' discount (in shares)   12,650,000            
Proceeds from sale of common stock, net of underwriters’ discount and transaction costs 380,620 $ 127   380,493        
Issuance of unrestricted stock (in shares)   8,820,482            
Issuance of unrestricted stock 285,445 $ 87   285,358        
Issuance of restricted stock (in shares)   36,223            
Issuance of restricted stock 0              
Shares withheld to satisfy minimum tax withholding (in shares)   (85,469)            
Shares withheld to satisfy tax withholding (5,128) $ 0   (5,128)        
Declared dividend (87,344)   (11,469) (50,244)     (25,631)  
Amortization of stock-based compensation 8,832     8,832        
Net income (16,718)   11,469   (10,071)   (21,969) 3,853
Change in fair value of derivatives 2,597         1,362 1,235  
Redemption of Series B Preferred Stock (145,000)   (145,000)          
Issuance of common units for acquisition properties 1,814,936           1,814,936  
Exchange of Non-controlling Interests — Common units in the operating partnership for common stock (in shares)   934,728            
Exchange of Non-controlling Interests — common units in the operating partnership for common stock 0 $ 9   20,835     (20,844)  
Change in fair value of derivatives $ 2,597              
Ending balance (in shares) at Dec. 31, 2015 89,153,780 89,153,780            
Ending balance at Dec. 31, 2015 $ 3,729,037 $ 891 0 1,710,979 (44,955) (1,081) 1,800,578 262,625
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Contributions 33,996             33,996
Distributions (1,303)             (1,303)
Proceeds from sale of common stock, net of underwriters' discount (in shares)   47,010,695            
Proceeds from sale of common stock, net of underwriters’ discount and transaction costs 1,449,581 $ 470   1,449,111        
Issuance of unrestricted stock (in shares)   590,520            
Issuance of unrestricted stock 6 $ 6            
Shares withheld to satisfy minimum tax withholding (in shares)   (262,760)            
Shares withheld to satisfy tax withholding (8,427) $ (3)   (8,424)        
Declared dividend (117,819)     (90,005)     (27,814)  
Amortization of stock-based compensation 14,654     13,609     1,045  
Net income 43,122       27,984   5,848 9,290
Change in fair value of derivatives (5,300)              
Change in fair value of derivatives 5,942         10,577 (4,635)  
Redemption of common units in the operating partnership $ (1,446,039)     34,124     (1,480,163)  
Ending balance (in shares) at Dec. 31, 2016 136,492,235 136,492,235            
Ending balance at Dec. 31, 2016 $ 3,702,750 $ 1,364 $ 0 $ 3,109,394 $ (16,971) $ 9,496 $ 294,859 $ 304,608